Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.

@article{Saver2013TimeTT,
  title={Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.},
  author={Jeffrey L. Saver and Gregg C Fonarow and Eric E Smith and Mathew J Reeves and Maria V Grau-Sepulveda and Wenqin Pan and DaiWai M Olson and Adrian F. Hernandez and Eric D. Peterson and Lee H Schwamm},
  journal={JAMA},
  year={2013},
  volume={309 23},
  pages={2480-8}
}
IMPORTANCE Randomized clinical trials suggest the benefit of intravenous tissue-type plasminogen activator (tPA) in acute ischemic stroke is time dependent. However, modest sample sizes have limited characterization of the extent to which onset to treatment (OTT) time influences outcome; and the generalizability of findings to clinical practice is uncertain. OBJECTIVE To evaluate the degree to which OTT time is associated with outcome among patients with acute ischemic stroke treated with… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 77 times over the past 90 days. VIEW TWEETS
190 Citations
34 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 190 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 34 references

The relation between destination on hospital discharge and final 3 month disability outcome in acute ischemic stroke. Stroke

  • Q Zhang, JL Saver
  • Accessed May 31,
  • 2013

sentativeness of the Get With The Guidelines – Stroke Registry : comparison of patient and hospital characteristics among Medicare beneficiaries hospitalized with ischemic stroke

  • B Ovbiagele, JL Saver
  • 2012

Similar Papers

Loading similar papers…